Why is Mankind Pharma falling/rising?

As of 28-Jul, Mankind Pharma Ltd's stock price is currently at Rs 2,536.00, reflecting a decrease of Rs 56.1 or 2.16%. The stock has underperformed its sector by 2.24% today and reached an intraday low of Rs 2,536. The stock's performance over the past week shows a decline of 4.11%, while it has gained 8.49% over the past month. Despite a year-to-date decline of 11.85%, the stock has performed well over the past year with a return of 22.80%. The company benefits from high management efficiency, a low Debt to EBITDA ratio, and strong long-term growth in operating profit. However, there has been a notable decrease in investor participation, with delivery volume falling by 43.47% against the 5-day average, which may contribute to the recent price decline.
In the broader market context, the stock's short-term performance has been weaker than the benchmark, with the Sensex declining by 1.59% over the past week. While Mankind Pharma has outperformed the broader market over the past year, the recent drop in price and investor participation suggests a cautious sentiment among investors. The stock's liquidity remains adequate for trading, but the current downward movement may reflect broader market trends and investor sentiment rather than company fundamentals.